Status:
RECRUITING
Post-Market Product Surveillance of Intracranial ANeurysms Treated With Commercial ReGistered ACANDIS Devices in FrancE
Lead Sponsor:
Acandis GmbH
Conditions:
Intracranial Aneurysms
Eligibility:
All Genders
18+ years
Brief Summary
The aims of this clinical data collection are to investigate mortality, morbidity and neurological outcome 12 months after treatment of subject's intracranial aneurysm(s) and additionally to evaluate ...
Eligibility Criteria
Inclusion
- The subject has an intracranial aneurysm that can be treated with one of the Acandis device indicated for the treatment of intracranial aneurysms.
- The subject is 18 years of age or older.
- The subject is willing to comply with scheduled visits and examinations, per institution standard of care.
Exclusion
- The subject has provided tacit opposition to data collection.
- Any IFU warning will be considered for exclusion in the cohort.
Key Trial Info
Start Date :
December 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06940934
Start Date
December 1 2021
End Date
April 1 2027
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neuroradiologie Interventionnelle, CHU de Rouen (Charles Nicolle)
Rouen, France, 76000